Nu Skin Enterprises Inc. said its fourth-quarter normalized net income was 63 cents per share, compared with the S&P Capital IQ consensus estimate of 73 cents per share.
EPS decreased 25.7% year over year from 85 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $36.5 million, a decline of 29.2% from $51.6 million in the year-earlier period.
The normalized profit margin fell to 6.4% from 8.5% in the year-earlier period.
Total revenue decreased 6.1% on an annual basis to $572.2 million from $609.6 million, and total operating expenses decreased on an annual basis to $510.5 million from $518.3 million.
Reported net income decreased 23.2% year over year to $35.8 million, or 62 cents per share, from $46.6 million, or 77 cents per share.
For the year, the company's normalized net income totaled $2.35 per share, compared with the S&P Capital IQ consensus normalized EPS estimate of $2.88.
EPS declined 35.0% from $3.62 in the prior year.
Normalized net income was $138.8 million, a fall of 36.9% from $220.1 million in the prior year.
Full-year total revenue declined 12.5% on an annual basis to $2.25 billion from $2.57 billion, and total operating expenses fell 9.7% on an annual basis to $2.00 billion from $2.22 billion.
The company said reported net income declined 29.8% year over year to $132.9 million, or $2.25 per share, in the full year, from $189.4 million, or $3.11 per share.